Clinical Trial Update: Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Nerispirdine's impact on visual function in patients with multiple sclerosis, including optic neuritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Optic Neuritis

Drugs mentioned

• Nerispirdine (nerispirdine)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis, Optic Nerve | Phase 2 | Status: COMPLETED